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Conducting  clinical  trials  to prevent  and  treat  infectious  diseases  in pregnancy  is  essential  to  saving
maternal  and  newborn  lives,  though  it is fraught  with  challenges.  We  have  been  conducting  research  in
malaria  treatment  and  prevention  in  children  and  pregnant  women  in Blantyre,  Malawi  for over a  decade.linical trials
regnancy
nfectious diseases
ntenatal care
eneralizability
nternational health
Here,  we  review  some  of  the unique  challenges  that  we have  faced  in  leading  research  studies  that  with
rigor  and  integrity  and  maintaining  the highest  ethical  standard.  We  conclude  with  concrete  strategies
to  overcome  some  of  the apparent  obstacles  that  frequently  focus  on  building  trust  through  bidirectional
communication  with  local  health  workers  and  communities.  We  also  highlight  the  key role  of  local  and
international  investigators  to advocate  for the  health  of the  communities  in which  they  work.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).. Introduction
Most clinical researchers would have had the experience of a
isease sharply decreasing in prevalence, or even virtually disap-
earing, while the disease is under study. The conditions of a clinical
rial often alter the natural history of diseases and the prevalence
f adverse outcomes. These complicating factors limit the ability
o conduct ethical studies that provide generalizable information,
specially in resource-limited settings, where the reality of access
o health care and disease prevention is often much less than the
tated standard of care [1]. In addition, it contributes to the failure to
onduct adequately powered studies to detect differences between
reatment and control groups because the overall rate of either the
isease or adverse outcome of interest decreases signiﬁcantly due
o the conditions of the clinical trial.
The challenges of conducting clinical studies among pregnant
omen have been well articulated in previous reviews [2,3]. Our
eview focuses on unique challenges of clinical trials in resource
imited settings using illustrative examples; our research group has
ncountered conducting studies to evaluate strategies to prevent
nd treat malaria among pregnant women in Malawi. We  highlight
∗ Correspondence at: 685 W.  Baltimore St. HSF-1, Room 480, Baltimore, MD 21201,
SA. Tel.: +1 410 706 5328; fax: +1 410 706 1204.
E-mail address: mlaufer@medicine.umaryland.edu (M.K. Laufer).
ttp://dx.doi.org/10.1016/j.vaccine.2015.08.042
264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article ucommon issues that would apply to a wide range of diseases. We
end the discussion with several key lessons learned from our expe-
riences and strategies that have overcome some of the challenges
that we  and others have faced. This discussion is not intended to
be exhaustive but rather a framework in which to consider and
trouble-shoot the unique obstacles.
2. Typical scenario
In clinical trials, to treat or prevent infectious diseases in
pregnant women, the study design is typical. Pregnant women at
risk of an infectious disease are enrolled at a standardized and often
early point in their pregnancy when they are assumed to be unin-
fected. At baseline, all participants are expected to be at a similar
risk of an incident infection over the course of their participation.
They are randomized to receive either the intervention or a placebo
or standard of care. The primary aim is to measure the effect of the
intervention on the incidence of an infection during pregnancy or
in the infant or on the cure rate. The additional key aim is often
to assess the safety of the intervention by measuring its impact on
maternal, perinatal and fetal outcomes.
Prospective participants undergo a screening process to ensure
that they meet speciﬁed eligibility criteria and to exclude women
who may  be at increased risk of harm through study participation.
In many cases, the women  and their pregnancies are scrutinized
and followed carefully. Accurate and complete capture of perinatal
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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utcomes is often essential to assessing the safety of interventions
uring pregnancy [4].
. Study design
.1. Sample size considerations
Studies are designed based on baseline data, collected through
revious studies or public records. The prolonged process from
rant writing to start of the study virtually ensures that baseline
ata will be outdated by the time the new clinical trial begins.
his is true for designing clinical trials in all settings as secular
nd seasonal variations are the hallmark of communicable diseases.
n resource limited settings, the added elements of sporadic and
npredictable availability of resources lead to changes in preven-
ive strategies available in the general community. As an example,
n our continuous surveillance of malaria prevalence in pregnant
omen and in communities, we have consistently found that a
ingle bed net campaign may  decrease malaria prevalence dra-
atically for one year and then return to the previous baseline
evel subsequently (Boudova and Laufer, unpublished data). Public
ecords are also unreliable and inconsistent. Deﬁnitions that dis-
inguish stillbirths from miscarriages and growth restriction from
reterm birth require accurate antenatal assessment of gestational
ge, which is rarely available [5].
Another unique characteristic of research in the most resource-
imited environments is the disparity between standard of
reventive and curative treatment policies and the access that most
omen have to those treatments [1,6]. As discussed below, inves-
igators are obligated to provide clinical trial participants with, at
east, the basic care to which they are entitled. While this obli-
ation is essential, when such services are not available to the
opulation at large, such care alone will likely have an effect on
he natural history of a wide range of infectious diseases and also
he incidence of adverse perinatal and neonatal outcomes. A signif-
cant decrease in baseline rates of these key outcome measures can
imit the power of clinical studies. In our studies, the provision of
ed nets to prevent malaria is a key element of the antenatal care
ackage, though the local government clinic frequently experience
tock outs. Active detection and treatment of anemia, hypertension,
rinary tract infections and sexually transmitted diseases that often
oes not occur in busy public clinics, likely improves the perinatal
nd infant outcomes among all participants.
.2. Eligibility criteria
To ensure some uniformity in the study population, gestational
ge windows are speciﬁed in the eligibility criteria [2]. Assessment
f gestational age of the pregnancy is typically performed by calcu-
ation based on last menstrual period or measurement of the fundal
eight. Even when implemented correctly, these techniques do not
rovide consistent results [7–9]. In our experience, women  often do
ot recall their last menstrual period and busy midwives often do
ot have time to measure the fundal height or do not have measur-
ng tapes. Visual inspection and palpation of the abdomen are used
o give a rough estimate of gestational age. For a clinical trial, more
recise measurements are required and the use of ultrasound dat-
ng is essential. Portable and inexpensive ultrasound machines are
ow available for use in resource-limited settings [10]. However,
his capacity to accurately date pregnancies requires training and
upervision as described below.
When participants are expected to be enrolled prior to the third
rimester, recruitment may  be difﬁcult. Reaching women  during
he early stages of their pregnancy poses a challenge. There are
ocial concerns about revealing ones pregnancy “too early”. Women
ypically present for their ﬁrst antenatal visit late in their second or3 (2015) 6401–6405
even in their third trimester [11–14], limiting the ability to capture
data during early fetal development.
3.3. Follow up
The ability to maintain the follow up schedule through preg-
nancy has been identiﬁed previously as a barrier to obtaining
adequate safety data [2]. Follow up fatigue often sets in. The World
Health Organization recommends a minimum of four antenatal
care visits. For active case detection, administration of interven-
tions and monitoring for adverse events, participants are often
asked to attend more antenatal visits than this commonly-accepted
minimum. Although, transportation costs are reimbursed for par-
ticipants at all scheduled visits, increased antenatal visits compete
with other obligations for participants as well as the physical
fatigue of pregnancy, all contributing to the risk of reduced adher-
ence to follow up schedules over time.
There are local traditions that encourage women  to deliver their
infants at health facilities located close to their extended families.
These customs are essential because family members provide all
care for pregnant women  and their newborns. Although, we only
included women who  agreed to deliver their infant at the study des-
ignated health center; we  found that delivery plans changed over
the course of the pregnancy. As the ﬁrst antenatal visit coincided
with the ﬁrst public statement of the woman’s pregnancy, negoti-
ations about details of the delivery, especially, for women who are
pregnant for the ﬁrst time, evolve over the subsequent months.
Changes in participation as a result of adverse events experi-
enced during the study signiﬁcantly threaten the integrity of the
study. We  have observed a wide range of responses. Most often,
when complications related to pregnancy occur, participants are
grateful to the study team members for the medical care, logis-
tical support and advocacy they provide. Research clinicians and
nurses are able to help navigate the often complex health system
and provide care that is better than what is available through the
typical public health infrastructure. However, adverse events, even
when clearly unrelated to study intervention, often elicit suspicion
and fear. As a result, women who  experience complications of preg-
nancy either choose to discontinue study participation or withdraw
due to pressure from family members who attribute the complica-
tion to research participation. In these cases, loss to follow up is
strongly associated with pregnancy outcomes.
3.4. Detection of baseline illnesses and exclusion criteria
The eligibility criteria, especially, for trials of new interven-
tions that may  have unanticipated risks, are often strict. Potential
participants undergo extensive evaluation, often well beyond the
standard screening offered to women  in the antenatal settings, to
assess their eligibility for the study. Thus, women who would have
underlying illnesses that would otherwise remain undetected at
an early stage will be systematically excluded from the clinical
trial. This is undoubtedly essential for the protection of the wel-
fare of those who enroll. However, conclusions about safety and
efﬁcacy in a real life population are severely limited. Outcomes
will be demonstrated in women  with or without conditions, which
were identiﬁed through screening tools that may  never be avail-
able in routine setting, so a conclusion, for example, that a drug is
safe as long as a pregnant women do not have hypertension may
not be relevant in the setting where blood pressure is not carefully
monitored.3.5. Capturing endpoints
Deliveries are unpredictable. They occur day and night, though
typically more often in the night [15]. This trend has not been
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aintained recently in the United States [16], but likely remains
rue in resource-limited settings. They can occur in any location,
ot always at a health facility and certainly not at the previously
dentiﬁed health facility of choice. Capturing data from maternity
ards is perhaps one of the most challenging of all health care
nvironments. They are chaotic places where frequently a single
urse midwife is overseeing multiple women in labor and may  be
esponsible for both maternal and neonatal care during the deliv-
ry. Women  are discharged home quickly, with limited assessment
f the infant. While birth weight is often recorded, its accuracy is
ot assured. Other key measurements such as height and head cir-
umference may  not be routinely recorded. Often temperature is
ot measured routinely so fever and hypothermia are usually not
etected until it is severe.
. Cultural, ethical and regulatory concerns
.1. Consent
One of the basic tenets of research ethics is autonomy – individ-
al’s capacity to deliberate about own goals and to act under the
irection of such deliberation without manipulation by external
orces [17]. Individual autonomy is more complex in settings where
ommunity and family structures have a strong inﬂuence on indi-
idual choices. This is a unique challenge to pregnant women  as the
ecisions that affect the fetus often are perceived to lie with people
ther than the mother. Subpart B of 45 Code of Federal Regulations
art 46 clearly states that for studies in which the risk to the fetus
s not greater than minimal, consent of just the pregnant woman is
ufﬁcient [18]. However, our experience is that this is not how deci-
ions are made. Key inﬂuential family members, especially mother
n law and other paternal matriarchs are often the decision mak-
rs. Although, consultation with family members does not negate
ndividual autonomy, in fact is an exercise of it, this does present
ome unique challenges.
For studies that seek to enrol women at their ﬁrst antenatal visit,
he need to consult individuals who are not present during the visit
s problematic. If randomization to an intervention vs. standard of
are is meant to occur at the ﬁrst antenatal visit, then a delay in
rovision of at least a standard intervention raises the concern that
 potential participant will receive inadequate antenatal care while
he is deciding whether or not to join the study. The period without
he protection of standard antenatal intervention may  increase the
eriod of the pregnant woman’s vulnerability to infection and there
s a risk that the woman will not return in a timely manner espe-
ially if she decides against study participation. Our staff routinely
sks potential participants if there are other key decision makers
ith whom they would like to discuss their participation prior to
nrolment. However, we have experienced substantial numbers of
ithdrawals of consent following ﬁrst visits because of the input of
nﬂuential family members. It is tempting to insist upon identifying
nd consulting key decision makers, however, this also disempow-
rs the woman from making decisions.
.2. Trust
Enrolment into a study depends on how much trust the potential
articipant has in the study and its staff. This trust is largely based
n the expectation that the study will maximize good and mini-
ize harm. With pregnancy, these expectations are held even more
trongly with the anticipation of healthy outcomes and the intu-
tive understanding that bad outcomes can occur without warning.
n a setting of extended families and strong community bonds, the
tudy needs to gain the trust of not only the participants, but also
heir husbands, parents and traditional leaders. The community3 (2015) 6401–6405 6403
carefully scrutinizes any new activities that are related to preg-
nancy health care. Mistrust can develop quickly and can breed
misconceptions that have the potential to derail study recruitment
and follow up. In our study, the common misconceptions were
that the study team collects human specimens including blood and
placentas for proﬁt gains or witchcraft. Other community mem-
bers have claimed that study participation leads to poor pregnancy
outcomes and infant death.
5. Generalizability
As it is clear from the above discussion, participants who attend
antenatal care within the desired gestational age range, have fam-
ily support and meet the strict inclusion and exclusion criteria,
represent a unique subset of pregnant women. Through their par-
ticipation in the clinical trial, they undergo screening and treatment
for many infectious and non-communicable conditions that will
alter pregnancy outcomes. The question then always arises – To
what extent does the outcome of the clinical trial predict the impact
of implementation of the intervention under real-life conditions?
6. Proposals to prevent and mitigate
6.1. Partnering with local health care providers
The local health care facilities providing maternal care can play
a pivotal role in recruitment of participants and tracking of delivery
outcomes. In our studies at a local health center, nurse midwives
from these facilities were trained on the speciﬁcs of the studies,
including participant recruitment, identiﬁcation of a study partic-
ipant in labor and collection of delivery outcomes. Though there
is inherent tension between government and study personnel and
assigned duties and responsibilities, the local study team focused
intensely on maintaining a collegial and cooperative relationship
with the local health center staff.
Another level of partnership was  with community health care
workers (CHWs), whose formal job is implementation of public
health interventions at community level and are often consulted
by community members on various health topics. The CHWs were
trained on the details of the clinical studies, the screening pro-
cess and basics of what potential participants should expect if they
choose to join the study. Their involvement was instrumental in
engaging in a strong working relationship with the community.
They also serve as trusted advisors to community members and
especially appeal to individuals who have some inherent distrust of
the government health infrastructure. Thus, in addition to facilitat-
ing communication, they also helped the study to gain acceptance.
6.2. Community engagement
To maintain strong lasting ties with the community, the site,
with the help of the research ethics committee, established a com-
munity advisory group, a committee of volunteers from the study
catchment area trained on the basics of clinical trials, research
ethics and the speciﬁcs of ongoing studies. The group represents
the interests of the community with regard to ongoing and new
studies. It also acts as a liaison between the research team and the
community, educating people about participation in clinical trials
and providing a platform of ongoing communication between the
research team and the community.
Because of the reluctance to reveal pregnancy early, it is difﬁ-
cult to encourage discussion about pregnancy related issues prior
to initiating antenatal care. There is no speciﬁc target audience for
women who are pregnant but have not reached antenatal care,
the fathers of their children and their parents. Information must
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each the entire community with the hope that in the short period
etween revealing pregnancy and attending the ﬁrst antenatal
linic visit, study participation is discussed.
To reach out to men, parents and others with inﬂuence over
omen’s participation in clinical studies that are otherwise not
ccessible because they do not attend antenatal clinics, site staff
onducted community meetings around the catchment area. To
ttract these key decision makers, the activities were organized in a
ormal way through community leaders and included performance
y a local drama group. The activities targeted common miscon-
eptions about study participation and pregnancy outcomes and
ccommodated questions from community members to address
heir concerns.
.3. Basic use of ultrasound
The use of ultrasound for dating pregnancies prior to the
hird trimester is an attainable goal. Portable, rugged ultrasound
achines are available for use in resource limited settings for a wide
ange of obstetric and non-obstetric uses. We  have successfully
stablished on-site ultrasound capacity for gestational age dating
n the second trimester at our research clinic in Malawi [19]. A US
rained obstetrician spent one week in person training key staff
embers in the technique. For four months, the US expert reviewed
ll scans and provided real-time feedback. With the intense quality
ontrol procedures, several site staff became highly skilled in this
peciﬁc activity. They subsequently trained new staff members and
erved as their mentors as the new trainees began to conduct the
cans themselves. Today, we conduct 10-15% quality assurance on
ll scans to ensure that the quality remains high. The endeavor,
owever, is not trivial.
.4. Providing beneﬁts to early enrolment in antenatal care
In the absence of interventions that get at the very deep seeded
eluctance among women to identify themselves as being pregnant
20–22], clinical studies can offer incentives to early enrolment in
ntenatal services. One obvious beneﬁt in studies is the relief of
he costs of antenatal care to the individual woman. In this way,
ne of the leading barriers to antenatal care attendance, lack of
conomic means to register for care [12,23,24], can be overcome.
ith this support, the ﬁrst antenatal visit may  be perceived as less
f an investment and thus a decision that can be made earlier in
estation.
The ultrasound images are also novel and often highly desir-
ble beneﬁts of study participation and potentially incentive to
eek out antenatal care. If there are limited tangible beneﬁts to
nrolment in antenatal care and the care itself does not provide
dequate reassurance about the viability of the pregnancy, a live
mage of the fetus and a picture to take home to show to fam-
ly members has been strongly appreciated by study participants.
nvestigators in other Africa settings have had similar anecdotal
xperience [14,25,26] and a clinical trial is currently underway to
ssess the beneﬁt of routine ultrasounds in resource-limited sett-
ngs with the rigor of a randomized trial [27].
One unanticipated beneﬁt was the ability to conduct urine preg-
ancy tests. This capacity was not available at the government clinic
rom which we recruited study participants. Young women in their
rst pregnancy occasionally came to the government clinic to ascer-
ain whether they were pregnant and through the standard care,
regnancy would be diagnosed by history of last menstrual period
nd palpation, which was often indeterminate early in pregnancy.
omen  who were interested in being screened for study participa-
ion were offered urine pregnancy test if pregnancy was not clear
rom physical examination. These women were grateful for the3 (2015) 6401–6405
service provided by the study team and were eager study partici-
pants when they were enroled.
6.5. Flexibility and re-evaluation
Because of the unpredictable nature of communicable diseases
and the potential of unanticipated and sometime unmeasurable
factors that inﬂuence the local epidemiology, sample size and event
rate calculations must allow for some ﬂexibility. Changes in the
incidence of disease and adverse outcomes should be anticipated
and opportunities for re-evaluation should be built in to protocol
time lines. Sponsors should also be prepared to support changes in
these parameters when unpredictable ﬂuctuations occur.
6.6. Advocacy
Researchers from the local institutions and from abroad are
in a unique position of power. They often develop close working
relationships with public health leaders, make meaningful contrib-
utions to the health care provided in the community where they
work and help to translate scientiﬁc discoveries into public health
action. By functioning in close association with the public health
system, investigators experience ﬁrst-hand the challenges faced by
local health centers. We  therefore have an opportunity and even
a responsibility to advocate on behalf the communities we serve.
There is a selﬁsh view of this – by making the access to health
care in “real life” more similar to the conditions of clinical trials,
we improve the generalizability of our results – but we  believe we
have a moral obligation. Communities trust that researchers are
working to improve their health. While researchers think of this
role as contributing new scientiﬁc knowledge, we can and should
have an obligation work to make the best possible health care today
available to those communities who  are willingly volunteering to
improve the health of those who come after them.
7. Conclusion
Conducting clinical trials among pregnant women  in resource
limited settings presents unique epidemiological and ethical chal-
lenges including limited availability of baseline data, the quality of
standard of care when compared to international standards, unpre-
dictable changes in disease epidemiology and cultural beliefs. In our
decade of leading clinical studies of pregnant women in Malawi,
we have found that partnering the local health care system, com-
munity engagement, incentivizing study participation, and adding
ﬂexibility to study designs are essential to maintaining a successful
program.
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